Merck to Split Human Health Business into Two Divisions

Merck announced plans to divide its human health business into two separate divisions, separating its cancer franchise from non-oncology medicines, to mitigate the impact of Keytruda patent loss.

23 Feb, 11:58 — 23 Feb, 11:58

Post Share

Sources

Showing 1 of 2 sources

cnbcMostly Factual66d ago

Merck to create separate cancer business to offset Keytruda patent loss

Merck said on ⁠Monday it will split its human-health business into two divisions, separating its cancer franchise from ⁠its non-oncology ‌medicines.

Read full article →

Coverage Timeline

First report: cnbc · 23 Feb, 11:58|Full coverage: 2 · 1m|Window: 1m

Left-leaningCenterRight-leaning

cnbc23 Feb, 11:58First to report

Merck to create separate cancer business to offset Keytruda patent loss

seeking-alpha23 Feb, 11:59Latest update

PERSPECTA

PERSPECTA

Merck to Split Human Health Business into Two Divisions

Sources

Merck to create separate cancer business to offset Keytruda patent loss

Coverage Timeline

Merck to create separate cancer business to offset Keytruda patent loss

Merck to split human health unit into two divisions

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Bus Operator's Authority Nixed After Flyover Fire, Discount Violations

Seized Discaya-owned cars remain unsold after failed offers

Former Bus Conglomerate Employees File Criminal Complaints

PERSPECTA